Ichor Life Sciences, a full-service CRO, is expanding its clinical trial services to Australia, Europe, and the UK.
  
Ichor Clinical offers collaborative processes and service offerings with concierge and boutique CROs in Australia, the UK, and Ireland, that include trial design and startup, clinical trial site selection, recruitment planning and strategy, monitoring, data management and statistics, regulatory support, and trial close out. 
 
Lisa Sonneborn, MA, LMHC, President of Ichor Clinical, said, “Our mission is to act as a global catalyst, offering personalized global clinical trial services, strategy, and regulatory guidance to life sciences companies of all sizes, including small and medium-sized companies that require a superior level of service.” 
 
Dr. Tina Soulis, PhD, Founder and Director of Alithia Life Sciences, a full-service Australian CRO, said, “CROs that grasp the financial and operational benefits of early-stage clinical data in strategically selected countries can provide a distinct financial benefit to their clients, while also allowing for a seamless transition from early phase trials in Australia to later phase trials in the U.S.”
 
The collaboration is led by a team with leadership experience spanning the clinical trial process. Dr. Nicola Wall, Ph.D., Founder and CEO of Afortiori Development, a full-service CRO based in Ireland and the UK, said, “Our international strategy ensures bespoke, high-quality services for clinical trials, transcending geographical boundaries and navigating local regulatory and clinical landscapes. We are dedicated to maintaining consistently high standards globally, contributing effectively to the forefront of medical research advancements.”